Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
TP-0184
Sort By
Newest First
1 / 1
1 / 1
Advanced Solid Tumors
Tolero Pharmaceuticals Announces First Patient Dosed with Investigational Agent TP-0184 in Phase 1 Study of Patients with Advanced Solid Tumors
Tolero Pharmaceuticals
PR-M07-18-NI-096
Jul 27, 2018
